Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 29 studies | 38% ± 20% | |
classical monocyte | 27 studies | 47% ± 16% | |
endothelial cell | 24 studies | 39% ± 18% | |
monocyte | 23 studies | 32% ± 13% | |
endothelial cell of lymphatic vessel | 22 studies | 49% ± 18% | |
plasmacytoid dendritic cell | 16 studies | 32% ± 11% | |
non-classical monocyte | 14 studies | 25% ± 10% | |
conventional dendritic cell | 13 studies | 28% ± 14% | |
capillary endothelial cell | 13 studies | 50% ± 15% | |
type II pneumocyte | 12 studies | 31% ± 15% | |
pericyte | 11 studies | 53% ± 25% | |
endothelial cell of artery | 10 studies | 31% ± 14% | |
adipocyte | 10 studies | 70% ± 18% | |
dendritic cell | 8 studies | 30% ± 13% | |
vein endothelial cell | 8 studies | 30% ± 11% | |
myeloid cell | 8 studies | 49% ± 20% | |
smooth muscle cell | 7 studies | 40% ± 19% | |
erythrocyte | 7 studies | 50% ± 19% | |
platelet | 6 studies | 28% ± 10% | |
cardiac muscle cell | 6 studies | 78% ± 15% | |
mononuclear phagocyte | 5 studies | 31% ± 9% | |
endothelial cell of sinusoid | 5 studies | 48% ± 25% | |
erythroblast | 5 studies | 43% ± 19% | |
fibroblast | 5 studies | 36% ± 12% | |
alveolar macrophage | 4 studies | 22% ± 3% | |
leukocyte | 4 studies | 26% ± 11% | |
intermediate monocyte | 4 studies | 42% ± 17% | |
endothelial cell of vascular tree | 4 studies | 50% ± 15% | |
pancreatic A cell | 3 studies | 26% ± 3% | |
epithelial cell | 3 studies | 26% ± 5% | |
tissue-resident macrophage | 3 studies | 26% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 97% | 56858.91 | 445 / 459 | 80% | 28.69 | 895 / 1118 |
thymus | 95% | 7895.91 | 623 / 653 | 68% | 10.47 | 414 / 605 |
lung | 79% | 5074.90 | 455 / 578 | 62% | 7.49 | 717 / 1155 |
adipose | 100% | 73498.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 13811.36 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 23384.02 | 857 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 8454.65 | 747 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 14% | 754.71 | 36 / 258 | 68% | 17.07 | 156 / 230 |
liver | 2% | 69.23 | 4 / 226 | 79% | 18.65 | 319 / 406 |
skin | 23% | 1307.38 | 421 / 1809 | 55% | 10.99 | 260 / 472 |
esophagus | 36% | 1754.02 | 522 / 1445 | 39% | 5.08 | 71 / 183 |
kidney | 2% | 118.60 | 2 / 89 | 69% | 31.73 | 624 / 901 |
pancreas | 5% | 194.37 | 17 / 328 | 66% | 13.88 | 118 / 178 |
stomach | 28% | 1320.02 | 102 / 359 | 35% | 3.34 | 100 / 286 |
intestine | 38% | 2111.95 | 367 / 966 | 24% | 2.44 | 124 / 527 |
bladder | 19% | 1109.67 | 4 / 21 | 40% | 12.47 | 203 / 504 |
lymph node | 0% | 0 | 0 / 0 | 34% | 2.68 | 10 / 29 |
peripheral blood | 34% | 1974.67 | 320 / 929 | 0% | 0 | 0 / 0 |
uterus | 0% | 0 | 0 / 170 | 30% | 12.76 | 138 / 459 |
ovary | 1% | 39.19 | 2 / 180 | 27% | 2.07 | 115 / 430 |
blood vessel | 28% | 2474.21 | 370 / 1335 | 0% | 0 | 0 / 0 |
prostate | 2% | 77.92 | 4 / 245 | 14% | 0.95 | 71 / 502 |
brain | 1% | 30.55 | 18 / 2642 | 12% | 1.16 | 87 / 705 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.73 | 5 / 45 |
eye | 0% | 0 | 0 / 0 | 3% | 0.22 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097009 | Biological process | energy homeostasis |
GO_0031623 | Biological process | receptor internalization |
GO_0071726 | Biological process | cellular response to diacyl bacterial lipopeptide |
GO_0098900 | Biological process | regulation of action potential |
GO_0006911 | Biological process | phagocytosis, engulfment |
GO_0070508 | Biological process | cholesterol import |
GO_0006910 | Biological process | phagocytosis, recognition |
GO_0044539 | Biological process | long-chain fatty acid import into cell |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0060100 | Biological process | positive regulation of phagocytosis, engulfment |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0015912 | Biological process | short-chain fatty acid transport |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0071447 | Biological process | cellular response to hydroperoxide |
GO_0070542 | Biological process | response to fatty acid |
GO_0070543 | Biological process | response to linoleic acid |
GO_0000165 | Biological process | MAPK cascade |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0038060 | Biological process | nitric oxide-cGMP-mediated signaling |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0042308 | Biological process | negative regulation of protein import into nucleus |
GO_1903428 | Biological process | positive regulation of reactive oxygen species biosynthetic process |
GO_0007155 | Biological process | cell adhesion |
GO_0034197 | Biological process | triglyceride transport |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0043277 | Biological process | apoptotic cell clearance |
GO_0033993 | Biological process | response to lipid |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0019915 | Biological process | lipid storage |
GO_0071223 | Biological process | cellular response to lipoteichoic acid |
GO_0045429 | Biological process | positive regulation of nitric oxide biosynthetic process |
GO_0030194 | Biological process | positive regulation of blood coagulation |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0042953 | Biological process | lipoprotein transport |
GO_0006629 | Biological process | lipid metabolic process |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0010744 | Biological process | positive regulation of macrophage derived foam cell differentiation |
GO_0019934 | Biological process | cGMP-mediated signaling |
GO_0015909 | Biological process | long-chain fatty acid transport |
GO_0010886 | Biological process | positive regulation of cholesterol storage |
GO_0150024 | Biological process | oxidised low-density lipoprotein particle clearance |
GO_0055096 | Biological process | low-density lipoprotein particle mediated signaling |
GO_0007596 | Biological process | blood coagulation |
GO_0050909 | Biological process | sensory perception of taste |
GO_2000121 | Biological process | regulation of removal of superoxide radicals |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0150094 | Biological process | amyloid-beta clearance by cellular catabolic process |
GO_0050892 | Biological process | intestinal absorption |
GO_0060907 | Biological process | positive regulation of macrophage cytokine production |
GO_0043254 | Biological process | regulation of protein-containing complex assembly |
GO_0031664 | Biological process | regulation of lipopolysaccharide-mediated signaling pathway |
GO_2000334 | Biological process | positive regulation of blood microparticle formation |
GO_0034121 | Biological process | regulation of toll-like receptor signaling pathway |
GO_1904646 | Biological process | cellular response to amyloid-beta |
GO_0140052 | Biological process | cellular response to oxidised low-density lipoprotein particle stimulus |
GO_0030301 | Biological process | cholesterol transport |
GO_0030299 | Biological process | intestinal cholesterol absorption |
GO_0006898 | Biological process | receptor-mediated endocytosis |
GO_0034381 | Biological process | plasma lipoprotein particle clearance |
GO_0035634 | Biological process | response to stilbenoid |
GO_0032735 | Biological process | positive regulation of interleukin-12 production |
GO_0001954 | Biological process | positive regulation of cell-matrix adhesion |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0015911 | Biological process | long-chain fatty acid import across plasma membrane |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_1900227 | Biological process | positive regulation of NLRP3 inflammasome complex assembly |
GO_0015908 | Biological process | fatty acid transport |
GO_1990000 | Biological process | amyloid fibril formation |
GO_0002532 | Biological process | production of molecular mediator involved in inflammatory response |
GO_0071404 | Biological process | cellular response to low-density lipoprotein particle stimulus |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0034383 | Biological process | low-density lipoprotein particle clearance |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_1990379 | Biological process | lipid transport across blood-brain barrier |
GO_0035579 | Cellular component | specific granule membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0009986 | Cellular component | cell surface |
GO_0071944 | Cellular component | cell periphery |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0030666 | Cellular component | endocytic vesicle membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005737 | Cellular component | cytoplasm |
GO_0005901 | Cellular component | caveola |
GO_0031526 | Cellular component | brush border membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0031092 | Cellular component | platelet alpha granule membrane |
GO_0150025 | Molecular function | oxidised low-density lipoprotein particle receptor activity |
GO_0071813 | Molecular function | lipoprotein particle binding |
GO_0015636 | Molecular function | short-chain fatty acid transmembrane transporter activity |
GO_0005324 | Molecular function | long-chain fatty acid transmembrane transporter activity |
GO_0035325 | Molecular function | Toll-like receptor binding |
GO_0038024 | Molecular function | cargo receptor activity |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0050431 | Molecular function | transforming growth factor beta binding |
GO_0070053 | Molecular function | thrombospondin receptor activity |
GO_0008289 | Molecular function | lipid binding |
GO_0005041 | Molecular function | low-density lipoprotein particle receptor activity |
GO_0030169 | Molecular function | low-density lipoprotein particle binding |
GO_0008035 | Molecular function | high-density lipoprotein particle binding |
GO_0005515 | Molecular function | protein binding |
GO_1901480 | Molecular function | oleate transmembrane transporter activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0070892 | Molecular function | lipoteichoic acid immune receptor activity |
GO_0005044 | Molecular function | scavenger receptor activity |
Gene name | CD36 |
Protein name | Platelet glycoprotein 4 (Glycoprotein IIIb) (PAS IV) (PAS-4) (Platelet glycoprotein IV) Mutant thrombospondin receptor Thrombospondin receptor Platelet glycoprotein 4 CD36 molecule Platelet glycoprotein 4 (Fatty acid translocase) (FAT) (Glycoprotein IIIb) (GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV) (GPIV) (Thrombospondin receptor) (CD antigen CD36) CD36 antigen |
Synonyms | GP4 hCG_17062 tcag7.257 GP3B |
Description | FUNCTION: Multifunctional glycoprotein that acts as a receptor for a broad range of ligands. Ligands can be of proteinaceous nature like thrombospondin, fibronectin, collagen or amyloid-beta as well as of lipidic nature such as oxidized low-density lipoprotein (oxLDL), anionic phospholipids, long-chain fatty acids and bacterial diacylated lipopeptides. They are generally multivalent and can therefore engage multiple receptors simultaneously, the resulting formation of CD36 clusters initiates signal transduction and internalization of receptor-ligand complexes. The dependency on coreceptor signaling is strongly ligand specific. Cellular responses to these ligands are involved in angiogenesis, inflammatory response, fatty acid metabolism, taste and dietary fat processing in the intestine (Probable). Binds long-chain fatty acids and facilitates their transport into cells, thus participating in muscle lipid utilization, adipose energy storage, and gut fat absorption (By similarity) . Mechanistically, binding of fatty acids activates downstream kinase LYN, which phosphorylates the palmitoyltransferase ZDHHC5 and inactivates it, resulting in the subsequent depalmitoylation of CD36 and caveolar endocytosis . In the small intestine, plays a role in proximal absorption of dietary fatty acid and cholesterol for optimal chylomicron formation, possibly through the activation of MAPK1/3 (ERK1/2) signaling pathway (By similarity) . Involved in oral fat perception and preferences . Detection into the tongue of long-chain fatty acids leads to a rapid and sustained rise in flux and protein content of pancreatobiliary secretions (By similarity). In taste receptor cells, mediates the induction of an increase in intracellular calcium levels by long-chain fatty acids, leading to the activation of the gustatory neurons in the nucleus of the solitary tract (By similarity). Important factor in both ventromedial hypothalamus neuronal sensing of long-chain fatty acid and the regulation of energy and glucose homeostasis (By similarity). Receptor for thrombospondins, THBS1 and THBS2, mediating their antiangiogenic effects (By similarity). Involved in inducing apoptosis in podocytes in response to elevated free fatty acids, acting together with THBS1 (By similarity). As a coreceptor for TLR4:TLR6 heterodimer, promotes inflammation in monocytes/macrophages. Upon ligand binding, such as oxLDL or amyloid-beta 42, interacts with the heterodimer TLR4:TLR6, the complex is internalized and triggers inflammatory response, leading to NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion, through the priming and activation of the NLRP3 inflammasome (By similarity) . Selective and nonredundant sensor of microbial diacylated lipopeptide that signal via TLR2:TLR6 heterodimer, this cluster triggers signaling from the cell surface, leading to the NF-kappa-B-dependent production of TNF, via MYD88 signaling pathway and subsequently is targeted to the Golgi in a lipid-raft dependent pathway (By similarity) . .; FUNCTION: (Microbial infection) Directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and the internalization of particles independently of TLR signaling. . |
Accessions | A0A0H3WDH4 A0A0H3WE82 A4D1B1 A0A516AFI0 A0A0A1EAI1 A0A0G3VR70 A0A2D1WBA2 ENST00000436384.5 ENST00000534394.5 E7EU05 ENST00000438020.5 H0YEE7 ENST00000544133.5 [P16671-2] ENST00000441034.2 A0A0G3VPD9 A0A0H3WBE8 E9PC45 Q13965 V5M404 ENST00000433696.6 [P16671-3] ENST00000488048.1 ENST00000419819.2 ENST00000426978.5 A0A0G3VSQ7 E7ERZ9 ENST00000394788.7 [P16671-1] A0A0G3VRE1 ENST00000482059.6 A0A0G3VQ57 ENST00000447544.7 [P16671-1] D9IX65 A0A0S2Z3J6 E9PLT1 ENST00000428497.5 E7EX47 ENST00000432207.5 [P16671-1] A0A0S2Z452 E7EWI4 D9IX64 ENST00000538969.5 [P16671-4] ENST00000413265.5 ENST00000309881.11 [P16671-1] P16671 ENST00000435819.5 [P16671-1] E7EVU1 A0A0H3WC42 A0A0H3WDK6 E9PJX8 A0A0A1ED81 D9IX63 |